MedTrace Logo

Clinical and Molecular Characterization of Axial Psoriatic Arthritis (PsA), A Pilot Study

NCT05925842 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2023-06-29

No results posted yet for this study

Summary

Objectives: To identify a candidate set of biomarkers specific to AxPsA. Overview: Clinical and imaging characterization of PsA patients will be combined with extensive molecular assessment of both liquid and tissue compartments to identify biomarkers which differentiate PsA patients with and without axial involvement

Conditions

Sponsors & Collaborators

  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis

    lead NETWORK

Principal Investigators

  • Philip Mease, MD · Group for Research and Assessment of Psoriasis and Psoriatic Arthritis

  • Vinod Chandran, MD · Group for Research and Assessment of Psoriasis and Psoriatic Arthritis

  • Oliver Fitzgerald, MD · Group for Research and Assessment of Psoriasis and Psoriatic Arthritis

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-25
Primary Completion
2024-02-29
Completion
2024-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05925842 on ClinicalTrials.gov